ÂÜÀòÂÒÂ×

Abdul Mullick is a seasoned executive in the biopharmaceutical industry with extensive experience in international business and marketing. Currently serving as the Chief International Business Officer and Managing Executive Officer at Kyowa Kirin Co., Ltd. since January 2023, Abdul previously held the positions of President and Executive Vice President for Rare Diseases at Kyowa Kirin International plc. from April 2018 to January 2023. Prior to this, Abdul was Executive Vice President of Global Marketing at Vifor Pharma and held various leadership roles at Genzyme, including VP & GM for Cardiovascular and Endocrinology and V.P & Head of Global Marketing for Rare Genetic Diseases. Experience also includes serving as Senior Global Brand Director at Novartis and Global Marketing Director at sanofi-aventis. Abdul holds a PhD in Molecular Biology from the University of Bristol, obtained between 1992 and 1995.